Hepatitis C Main Section
FDA-approved Monotherapies
FDA-approved Combination Therapies
Intron A
Roferon

Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Link to Hepatitis C Main Section

Psychiatric Disorders / Depression / Anti-depressants

Good Response to Hepatitis C Treatment in Patients with a History of Psychiatric Conditions - 12/11/07

Depression Due to Treatment with Pegylated Interferon plus Ribavirin May Be Under-diagnosed by Clinicians - 11/30/07

Past Psychiatric Disorders Do Not Reduce Hepatitis C Treatment Effectiveness in Genotype 2/3 Patients  - 4/20/07

Integrating Medical and Mental Health Care Improves Likelihood of Initiation and Adherence to Hepatitis C Treatment  11/21/06

Impact of Chronic Hepatitis C and Psychiatric Illness on Quality of Life - 8/11/06

Treating Hepatitis C in Patients with Pre-Existing Psychiatric Conditions - 6/16/06

Treatment-related Depression Is the Most Significant Factor Affecting Health-related Quality of Life in Chronic Hepatitis C - 3/21/06